drugset / Trial / NCT01723618
Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.
RandomizedParallel-groupOpen-label
Summary
The purpose of the study is to determine the plasma levels of CRD007 in patients with abdominal aortic aneurysms after the administration of single doses of tablets containing 10, 25 and 40 mg CRD007.
Timeline
- Start
- 2012-11
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CRD007 | Unknown | 10 mg | — |
| Subject | CRD007 | Unknown | 25 mg | — |
| Subject | CRD007 | Unknown | 40 mg | — |